Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

PHARMAKERN PORTUGAL, LDA.

NIF 507002571
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €4,773,723 67 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €4,773,723 67 contracts
A2 · Late Publication €3,204,173,868 1,501 contracts
Contract published to BASE more than 10 days after the signing date
LOW €3,204,173,868 1,501 contracts
A5 · Threshold Splitting €3,864,908 69 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €3,864,908 69 contracts
A6 · Low Competition €4,465,246 25 contracts
Only one bidder participated in a competitive procedure
MEDIUM €4,465,246 25 contracts
A9 · Price Overrun €4 1 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €4 1 contracts
A9 · Abnormal Price Reduction €3,794,480,832 715 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €3,794,480,832 715 contracts
C3 · Missing Mandatory Fields €2,108,158 38 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €2,108,158 38 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

20
€273,476,720
18
€213,926,468
33
€211,803,829
16
€208,525,828
10
€207,636,952
81
€207,107,976
31
€200,205,658
22
€193,359,958
64
€181,215,957
16
€173,317,763
6
€172,056,422
62
€165,193,406
38
€138,789,169
20
€122,290,185
66
€113,687,920
75
€103,035,139
70
€91,186,027
13
€90,170,102
125
€82,729,251
23
€76,243,379
Page 1 of 4 · 65 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 1 contracts

AP 1688 - AQUISIÇÃO DE PRODUTOS FARMACÊUTICOS
PT · 7277262 · Ao abrigo de acordo-qu...
A9 · Price Overrun
€4 2020-11-12
Overview
Total Value Won
€3,875,306,979
Contracts Won
2,026
Score 74270 · CRITICAL RISK
NIF
507002571
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

No director data imported yet.

Director and fiscal identity data for Portuguese companies can be found in the Registo Comercial (publicacoes.mj.pt).

Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned